Advertisement
US Stocks

Real Brands Stock Trades Near Penny Lows on Volume Surge

May 21, 2026
09:34 AM
5 min read

Key Points

RLBD stock trades at $0.00001 with 1M+ volume spike on OTC Pink Markets.

Company faces -22% net margin, negative cash flow, and $26,906 market cap.

Real Brands operates with one employee in struggling CBD market.

Stock down 99.99% from highs despite recent 900% YTD recovery from lows.

Be the first to rate this article

Real Brands, Inc. (RLBD) trades on the OTC Pink Markets (PNK) at microscopic levels as the hemp-derived CBD manufacturer battles severe financial headwinds. The stock hit $0.00001 per share with trading volume exploding to over 1 million shares, marking unusual activity for the struggling Rhode Island-based company. RLBD stock has collapsed 99.99% from historical highs, reflecting years of mounting losses and operational challenges. Investors tracking RLBD stock should understand the company’s precarious financial position before considering any positions.

Advertisement

RLBD Stock Price Action and Volume Dynamics

Real Brands stock trades at $0.00001 USD with zero daily movement, though volume surged to 1,009,100 shares compared to a typical 2-share average. The stock’s 50-day average sits at $0.00001 while the 200-day average stands at $0.0000523, indicating sustained downward pressure. Day trading range shows lows at $0.00001 and highs at $0.0001, reflecting extreme volatility typical of penny stocks. Track RLBD on Meyka for real-time price updates and volume changes.

The massive volume spike signals renewed retail interest despite the stock’s catastrophic decline. Year-to-date performance shows a 900% gain from January lows, yet the stock remains down 90% over one year and 99.99% from all-time highs. This recovery pattern reflects typical penny stock behavior where small price moves create outsized percentage swings. The current price level makes RLBD stock essentially worthless on a per-share basis.

Financial Deterioration and Profitability Crisis

Real Brands reports a market capitalization of just $26,906 USD with 2.69 billion shares outstanding, creating severe dilution. The company posted negative earnings per share of -$0.004 with no meaningful revenue generation relative to its cost structure. Net profit margin sits at -22.03%, meaning RLBD loses money on every dollar of sales. Operating cash flow remains deeply negative at -$0.0000512 per share, indicating the company burns cash continuously.

The balance sheet reveals critical liquidity problems with a current ratio of 0.032, far below the healthy 1.5 threshold. Working capital stands at negative $2.4 million while tangible asset value is negative $1.3 million. Return on equity shows 1.29%, though this metric is unreliable given the company’s negative book value. These metrics confirm RLBD stock faces existential financial stress with minimal assets and mounting liabilities.

CBD Market Position and Operational Challenges

Real Brands operates in the healthcare sector as a specialty drug manufacturer focused on hemp-derived CBD products. The company extracts CBD oil and isolate, wholesales these products, and manufactures consumer items including topical creams, cosmetics, tinctures, oils, capsules, and vape cartridges. Founded in 2011 and headquartered in North Providence, Rhode Island, RLBD employs just one full-time worker according to filings.

The company’s minimal workforce and negative cash flow suggest operations have essentially ceased or operate at skeleton-crew levels. CBD market competition intensified dramatically since RLBD’s founding, with larger players capturing market share. The company’s inability to generate positive cash flow or revenue growth indicates it cannot compete effectively in this crowded sector. RLBD stock reflects a business model that failed to scale or achieve profitability in a mature market.

Technical Indicators and Trading Signals

RLBD stock shows mixed technical signals with RSI at 46.28, suggesting neutral momentum without clear directional bias. The ADX reads 36.23, indicating a strong downtrend despite the recent volume spike. Williams %R sits at -100, signaling extreme oversold conditions typical of penny stocks near zero. Money Flow Index registers 98.61, showing overbought conditions that contradict the oversold RSI reading.

Rate of Change shows -90%, reflecting the stock’s catastrophic decline over the measured period. MACD, Bollinger Bands, and Keltner Channels all read zero or near-zero, indicating the stock trades at such microscopic levels that standard technical tools lose effectiveness. These technical signals suggest RLBD stock remains in a severe downtrend with no clear reversal catalyst visible. Meyka AI rates RLBD with a grade of B and a HOLD suggestion, though this reflects the stock’s extreme risk profile rather than investment merit.

Advertisement

Final Thoughts

Real Brands, Inc. (RLBD) trades at penny stock levels with a market cap under $27,000 and negative profitability across all metrics. The volume spike to over 1 million shares reflects speculative retail interest rather than fundamental improvement. With negative cash flow, minimal workforce, and a failed business model in the competitive CBD market, RLBD stock faces severe headwinds. Investors should recognize this as a distressed security with extreme risk and limited recovery prospects. The next earnings announcement scheduled for June 25, 2025, may provide clarity on the company’s operational status.

FAQs

Why is RLBD stock trading at such low prices?

RLBD stock collapsed due to years of negative earnings and cash burn. The $26,906 market cap reflects minimal asset value and ongoing losses, limiting competitiveness in the CBD market.

What does the volume spike mean for RLBD stock?

The 1M+ share volume surge indicates speculative retail trading rather than institutional confidence. Penny stocks experience volume spikes on minimal price moves due to low liquidity.

Is Real Brands still operating?

RLBD reports one full-time employee and negative cash flow, suggesting minimal operations. The next earnings report is scheduled for June 25, 2025.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)